Trial Profile
Low-dose thalidomide treatment for patients with relapsed and refractory multiple myeloma.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2011
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2011 New trial record